Cargando…
A retrospective study of the efficacy of intense pulsed light delivered by the Lacrystim® for meibomian gland dysfunction therapy
BACKGROUND: Meibomian gland dysfunction is the most common etiology of dry eye disease worldwide and intense pulsed light appears to be a promising treatment with encouraging results. Lacrystim® is a new IPL device (CE marking in 2019) and no studies have yet been published on it. We propose the fir...
Autores principales: | Trone, Marie-Caroline, Garcin, Thibaud, Ollier, Edouard, Thuret, Gilles, Gain, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356507/ https://www.ncbi.nlm.nih.gov/pubmed/35933379 http://dx.doi.org/10.1186/s12886-022-02531-7 |
Ejemplares similares
-
Intense pulsed light plus meibomian gland expression versus intense pulsed light alone for meibomian gland dysfunction: A randomized crossover study
por: Shin, Kyoung Yoon, et al.
Publicado: (2021) -
Different Number of Sessions of Intense Pulsed Light and Meibomian Gland Expression Combination Therapy for Meibomian Gland Dysfunction
por: Lee, Seung Hyeun, et al.
Publicado: (2022) -
Therapeutic Effect of Intense Pulsed Light (IPL) Combined with Meibomian Gland Expression (MGX) on Meibomian Gland Dysfunction (MGD)
por: Wei, Shanshan, et al.
Publicado: (2020) -
Low-Level Light Therapy in Association with Intense Pulsed Light for Meibomian Gland Dysfunction
por: Marques, João Heitor, et al.
Publicado: (2022) -
Evaluation of the Safety and Effectiveness of Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction
por: Jiang, Xiaodan, et al.
Publicado: (2016)